SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles

US Stock Market Move | Nasdaq rose 1%, most of the technology stocks increased, Intel Corporation (INTC.US) rose nearly 11%.

Tesla, Inc. CEO Musk's rocket company SpaceX accelerates the listing process and aims to build the world's first in-orbit AI data center.

US Stock Market Move | Storage sector continues to strengthen, with Micron Technology, Inc. (MU, US) and Western Digital Corporation (WDC, US) both gaining over 5%.
US Stock Market Move | Nasdaq rose 1%, most of the technology stocks increased, Intel Corporation (INTC.US) rose nearly 11%.

Tesla, Inc. CEO Musk's rocket company SpaceX accelerates the listing process and aims to build the world's first in-orbit AI data center.

US Stock Market Move | Storage sector continues to strengthen, with Micron Technology, Inc. (MU, US) and Western Digital Corporation (WDC, US) both gaining over 5%.

RECOMMEND

Moving Toward “7*24 Hour” Trading! NYSE Seeks Approval For “All‑Weather Blockchain Trading Platform”
21/01/2026

China Internet 2026: Under Pressure From ByteDance, Major Players Launch Full‑Scale Contest For AI Entry Points
21/01/2026

Hong Kong Equity Refinancing Opens Strong In 2026, Raising Over HKD 27 Billion
21/01/2026


